Panelists in this video:
+ Dr Prashant Musmade, Data Reliability Officer, Glenmark Pharmaceuticals (Moderator)
+ Dr Varda Bapat, COO, RV Lifesciences
+ Mr Anshu Manocha, Site Head (Executive GM), Indoco Remedies
+ Dr Sanjay Toshniwal, Central Council Member, Pharmacy Council of India, New Delhi
+ Mr Manoj Patil, DGM-Production, Ajanta Pharma
Key Highlights:
[1] Automation and digitalisation in the pharma industry has ushered real-time monitoring of systems and equipment, reduced manual errors, and ensured better regulatory compliance and quality of products
[2] A strong IPR incentivises innovation, protects against infringement, and gives a competitive edge to pharma companies
[3] Aurangabad’s skilled manpower, access to critical resources like water and transport, a conducive business climate, and favourable government policies make it a key hub for the pharma sector
[4] Industry-academia collaborations are crucial for the industry’s progress. They will help create industry-ready talent, encourage innovation, and drive value creation faster and more effectively
[5] Pharma education has to evolve and transform to keep pace with changing market demands and advancements in technology to create a future-ready talent pool